Market Overview

Recap: Inovio Pharmaceuticals Q3 Earnings

Share:

Shares of Inovio Pharmaceuticals (NASDAQ:INO) increased 2.94% in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share fell 4.00% year over year to ($0.26), which missed the estimate of ($0.19).

Revenue of $236,178,000 up by 27145.14% year over year, which beat the estimate of $3,050,000.

Outlook

Inovio Pharmaceuticals hasn't issued any earnings guidance for the time being.

Inovio Pharmaceuticals hasn't issued any revenue guidance for the time being.

How To Listen To The Conference Call

Date: Nov 09, 2020

Time: 04:30 PM

ET Webcast URL: https://www.webcaster4.com/Webcast/Page/2021/38428

Price Action

52-week high: $33.79

Company's 52-week low was at $2.19

Price action over last quarter: down 40.29%

Company Overview

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

 

Related Articles (INO)

View Comments and Join the Discussion!

Posted-In: Earnings